- Continuous Glucose Monitoring in the Hospital
-
M. Citlalli Perez-Guzman, Trisha Shang, Jennifer Y. Zhang, Donna Jornsay, David C. Klonoff
-
Endocrinol Metab. 2021;36(2):240-255. Published online March 31, 2021
-
DOI: https://doi.org/10.3803/EnM.2021.201
-
-
11,516
View
-
511
Download
-
13
Citations
-
 Abstract
 PDF PubReader  ePub  Crossref - TDM
- Continuous glucose monitors (CGMs) have suddenly become part of routine care in many hospitals. The coronavirus disease 2019 (COVID-19) pandemic has necessitated the use of new technologies and new processes to care for hospitalized patients, including diabetes patients. The use of CGMs to automatically and remotely supplement or replace assisted monitoring of blood glucose by bedside nurses can decrease: the amount of necessary nursing exposure to COVID-19 patients with diabetes; the amount of time required for obtaining blood glucose measurements, and the amount of personal protective equipment necessary for interacting with patients during the blood glucose testing. The United States Food and Drug Administration (FDA) is now exercising enforcement discretion and not objecting to certain factory-calibrated CGMs being used in a hospital setting, both to facilitate patient care and to obtain performance data that can be used for future regulatory submissions. CGMs can be used in the hospital to decrease the frequency of fingerstick point of care capillary blood glucose testing, decrease hyperglycemic episodes, and decrease hypoglycemic episodes. Most of the research on CGMs in the hospital has focused on their accuracy and only recently outcomes data has been reported. A hospital CGM program requires cooperation of physicians, bedside nurses, diabetes educators, and hospital administrators to appropriately select and manage patients. Processes for collecting, reviewing, storing, and responding to CGM data must be established for such a program to be successful. CGM technology is advancing and we expect that CGMs will be increasingly used in the hospital for patients with diabetes.
-
Citations
Citations to this article as recorded by  - The Need for Data Standards and Implementation Policies to Integrate CGM Data into the Electronic Health Record
Juan Espinoza, Nicole Y. Xu, Kevin T. Nguyen, David C. Klonoff
Journal of Diabetes Science and Technology.2023; 17(2): 495. CrossRef - Continuous Glucose Monitoring for Patients with COVID-19 Pneumonia: Initial Experience at a Tertiary Care Center
Adrian G. Dumitrascu, Michelle F. Perry, Rebecca J. Boone, Maria P. Guzman, Razvan M. Chirila, Allyson W. McNally, Dorin T. Colibaseanu, Shon E. Meek, Colleen T. Ball, Launia J. White, Ana-Maria Chindris
Endocrine Practice.2023; 29(3): 155. CrossRef - More Green, Less Red: How Color Standardization May Facilitate Effective Use of CGM Data
Richard M. Bergenstal, Gregg D. Simonson, Lutz Heinemann
Journal of Diabetes Science and Technology.2022; 16(1): 3. CrossRef - Continuous glucose monitoring in the hospital: an update in the era of COVID-19
Chikara Gothong, Lakshmi G. Singh, Medha Satyarengga, Elias K. Spanakis
Current Opinion in Endocrinology, Diabetes & Obesity.2022; 29(1): 1. CrossRef - Breakthrough technology for in-hospital glucose monitoring
David Kerr, David Klonoff
The Lancet Diabetes & Endocrinology.2022; 10(5): 304. CrossRef - The Role of the Diabetes Care and Education Specialist in the Hospital Setting
The Science of Diabetes Self-Management and Care.2022; 48(3): 184. CrossRef - Real-Time Monitoring of Blood Parameters in the Intensive Care Unit: State-of-the-Art and Perspectives
Rebecca Bockholt, Shaleen Paschke, Lars Heubner, Bergoi Ibarlucea, Alexander Laupp, Željko Janićijević, Stephanie Klinghammer, Sascha Balakin, Manfred F. Maitz, Carsten Werner, Gianaurelio Cuniberti, Larysa Baraban, Peter Markus Spieth
Journal of Clinical Medicine.2022; 11(9): 2408. CrossRef - Novel Glycemic Index Based on Continuous Glucose Monitoring to Predict Poor Clinical Outcomes in Critically Ill Patients: A Pilot Study
Eun Yeong Ha, Seung Min Chung, Il Rae Park, Yin Young Lee, Eun Young Choi, Jun Sung Moon
Frontiers in Endocrinology.2022;[Epub] CrossRef - Stress-Induced Hyperglycemia: Consequences and Management
Deepanjali Vedantam, Devyani S Poman, Lakshya Motwani, Nailah Asif, Apurva Patel, Krishna Kishore Anne
Cureus.2022;[Epub] CrossRef - Hospital Diabetes Meeting 2022
Jingtong Huang, Andrea M. Yeung, Kevin T. Nguyen, Nicole Y. Xu, Jean-Charles Preiser, Robert J. Rushakoff, Jane Jeffrie Seley, Guillermo E. Umpierrez, Amisha Wallia, Andjela T. Drincic, Roma Gianchandani, M. Cecilia Lansang, Umesh Masharani, Nestoras Math
Journal of Diabetes Science and Technology.2022; 16(5): 1309. CrossRef - Staff knowledge, attitudes and practices regarding glycaemic management in adult intensive care units: A national survey
Miao Huang, Ruiqi Yang, Chuanlai Zhang, Xiuni Gan
Nursing in Critical Care.2022;[Epub] CrossRef - Effects of Patient-Driven Lifestyle Modification Using Intermittently Scanned Continuous Glucose Monitoring in Patients With Type 2 Diabetes: Results From the Randomized Open-label PDF Study
Hun Jee Choe, Eun-Jung Rhee, Jong Chul Won, Kyong Soo Park, Won-Young Lee, Young Min Cho
Diabetes Care.2022; 45(10): 2224. CrossRef - The Devil Is in the Details: Use, Limitations, and Implementation of Continuous Glucose Monitoring in the Inpatient Setting
Rebecca Rick Longo, Renu Joshi
Diabetes Spectrum.2022; 35(4): 405. CrossRef
|
KES
